[ad_1]
‘0 vs 330 million doses (bottle)’.
This is the amount of vaccines for the new coronavirus infection (Corona 19) that the Korean and Japanese governments have secured so far for their citizens’ vaccines. The Japanese government has sold more than 300 million bottles of the Corona 19 vaccine, which entered phase 3 clinical trials, in the past four months. On the other hand, the Korean government has been repeating the word “insuring” for four months. Because of this, it is noted that the Korean government was completely defeated in the ‘War for Vaccine Sovereignty’.
According to the Nippon Geizai newspaper and the Asahi newspaper on the 17th, the Japanese government has 50 million bottles of Modena, an American biotechnology company, 120 million bottles of Pfizer, an American pharmaceutical company that is jointly developed with the German BioEntech, and Astra, a multinational pharmaceutical company developed jointly with the University of Oxford in the UK. Zeneca has insured 290 million bottles of Corona 19 vaccine, including 120 million bottles. Nova Bax also supplies at least 40 million bottles in the United States.
The amount of 330 million bottles is the amount left after 12.64 million Japanese hit twice this year. Usually a person gives the vaccine twice at regular intervals. Some 250 million vials of vaccine are needed and the Japanese government has obtained 50 million more.
There is no volume officially guaranteed by the Korean government. The government only said: “Five places have been put on the priority list.” This means that there is no progress in the negotiations. As public opinion about vaccine supply and demand deteriorated, Kwon Joon-wook, chief of the second vice president of Central Defense Response Headquarters, said on the 12th: “Even if we waive the advance payment, we will insure as much as may be possible”.
Due to government procrastination, the time for people to receive the Corona 19 vaccine is expected to be delayed. Japan plans to start a national vaccination in the first half of next year. The Korean government aims to vaccinate the vulnerable in the second half of next year.
I cannot guarantee that the vaccine will be assured in the second half of next year … K ‘shake’ in quarantine
The government is concerned about the ‘practice’ of security contracts
“I will give a vaccine to all the people for the first semester of next year.” (Japanese Prime Minister Yoshihide Suga)
The Japanese government went to great lengths to secure a Corona 19 vaccine as criticism grew for failing to quarantine a new coronavirus infection (Corona 19). Although he took the risk of losing the down payment due to a development failure, he began selling upfront. This is because they saw that securing a vaccine is at the core of corona prevention.
The Japanese government has also secured a budget of 6712 billion yen (about 7.99 trillion won) in this process. This is for free vaccines for the entire nation. Although some were concerned about the safety of the vaccines, the government decided to compensate the companies for the side effects. This is how the State compensates the loss if the pharmaceutical company compensates the person who has suffered the damage to health. An industry official said: “It is not easy to guarantee safety issues as this is the first corona vaccine to be developed, but the Japanese government stepped forward to ease the burden.”
The Korean government has always been cautious. The first vaccine will be released next month, but there are still questions about its safety. Kang-rip Kim, head of the Ministry of Food and Drug Safety, told a press conference on the 16th: “The messenger ribonucleic acid (mRNA) vaccine (which is being developed by Pfizer and Modena) needs further validation.” Said.
Due to this atmosphere, a vaccine pre-purchase contract could not be reached. The government announced in September that it would ensure vaccines abroad for 30 million people, 60% of the Korean population, but there is no progress. The United States, Europe, Mexico, and Australia are also buying vaccines in advance. Pfizer-Bio & Tech vaccines include the United States (600 million bottles), the European Union (EU, 300 million bottles), Mexico (34.4 million bottles), the United Kingdom (30 million bottles) , Australia (10 million bottles) and Canada (unpublished). I bought this in advance. Modena vaccines were contracted by the United States (100 million bottles), the EU (80 million bottles) and the United Kingdom (5 million bottles).
Some say SK Bioscience has decided to consign a corona vaccine for AstraZeneca and NovaVax, so part of the domestic production is expected to be secured for home use. However, not even this has been revealed. Since the government has not signed a purchase contract, there are concerns that it may be possible to receive it for domestic use after first supplying it to other countries.
Japan hinted that it is limited to domestic use of OCM. Takeda Pharmaceutical, which is expected to produce 250 million bottles of the NovaVax vaccine by consignment, made it clear through a press release that the Japanese production is for home use.
According to Asahi Shimbun and others, it is known that at least 40 million bottles will be supplied in Japan. The Japanese Ministry of Health, Labor and Welfare provided 30.1 billion yen (about 3.183 billion won) for the expansion of Takeda Pharmaceutical’s production facilities. Green Cross and SK Bioscience, a Korean vaccine OCM company, did not receive such support. Lee Eun-taek, a researcher at KB Securities, said: “There is a tendency for governments to invest funds and pre-purchase en masse from the early stage of (vaccine development).”
Reporter Kim Woo-seop / Tokyo = correspondent Jung Young-hyo [email protected]
